Craig Arnold - Medtronic Plc Independent Director

<div class='logoBackup' style='background:#8A0CCF;color: white;font-size:4em;padding-top: 15px;;'>ME</div>
MDT -- USA Stock  

Fiscal Quarter End: January 31, 2020  

Mr. Craig Arnold is Independent Director of the Company. Mr. Arnold was Chairman and Chief Executive Officer of Eaton Corporationrationration, a power management company, since June 1, 2016. From September 2015 to May 2016, Mr. Arnold served as President and Chief Operating Officer of Eaton Corporationrationration. Prior to that, Mr. Arnold served as the Vice Chairman and Chief Operating Officer, Industrial Sector, of Eaton Corporationrationration. From 2000 to 2008 he served as Senior Vice President of Eaton Corporationrationration and Group Executive of the Fluid Power Group of Eaton. Prior to joining Eaton, Mr. Arnold was employed in a series of progressively more responsible positions at General Electric Company from 1983 to 2000. Mr. Arnold was appointed to the Board of Directors of Eaton Corporationrationration in 2015. Mr. Arnold is a former director of Covidien plc.
Age: 57  Director Since 2015      
353 1 438 1700
Arnold was appointed to the Board of Directors of Eaton Corporationrationrationration in 2015. Within the past five years, Mr. Arnold served as a director of Covidien plc, a leading global healthcare products company. .

Craig Arnold Latest Insider Activity

Management Efficiency

The company has Return on Asset of 0.1 % which means that on every $100 spent on asset it made $0.1 of profit. This is way below average. In the same way, it shows return on shareholders equity (ROE) of 0.18 % implying that it generated $0.18 on every 100 dollars invested.
The company has 27.24 B in debt with debt to equity (D/E) ratio of 53.9 . This implies that the company may be unable to create cash to meet all of its financial commitments. Medtronic plc has Current Ratio of 2.62 demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due.

Similar Executives

Showing few of many executives


Barbara McNeilEdwards Lifesciences Corporatio
Robrecht MichielsEDAP TMS SA
William EcklesElectromed
David HoltzDynatronics Corporation
William LinkEdwards Lifesciences Corporatio
Larry BeardallDynatronics Corporation
Edward SchutterEstablishment Labs Holdings
James MillerSecond Sight Medical Products
John SaywardDigirad Corporation
Nicholas ValerianiEdwards Lifesciences Corporatio
Lisa GershEstablishment Labs Holdings
Scott KlostermanDynatronics Corporation
Aaron MendelsohnSecond Sight Medical Products
Dimitrios AngelisDigirad Corporation
Kieran GallahueEdwards Lifesciences Corporatio
Lisa ColleranEstablishment Labs Holdings
Vern KornelsenENCISION INC
Argil WheelockEDAP TMS SA
Stan EricksonElectromed

Entity Summary

Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. The company was founded in 1949 and is headquartered in Dublin, Ireland. Medtronic Plc operates under Medical Devices classification in USA and is traded on BATS Exchange. It employs 90000 people.Medtronic plc (MDT) is traded on BATS Exchange in USA. It is located in 20 On Hatch and employs 90,000 people. Medtronic Plc is listed under Medical Equipment category by Fama And French industry classification.

Medtronic plc Leadership Team

Bradley Lerman, Senior Vice President General Counsel, Corporate secretary
Scott Donnelly, Independent Director
Richard Anderson, Lead Independent Director
Ryan Weispfenning, Vice President - Investor Relations
Hooman Hakami, Executive Vice President and Group President of the Medtronic Diabetes Group
Elizabeth Nabel, Independent Director
Richard Kuntz, Senior Vice President and Chief Scientific, Clinical and Regulatory Officer
James Lenehan, Independent Director
Shirley Jackson, Independent Director
Robert White, Executive Vice President and President of Medtronic?s Minimally Invasive Therapies Group
Preetha Reddy, Independent Director
Craig Arnold, Independent Director
Robert Pozen, Independent Director
Kendall Powell, Lead Independent Director
Bryan Hanson, Executive VP and Group President of Minimally Invasive Therapies Group
Denise OLeary, Independent Director
Omar Ishrak, Chairman of the Board, Chief Executive Officer
Gary Ellis, CFO and Executive VP
Carol Surface, Chief Human Resource Officer, Senior Vice President
Karen Parkhill, Chief Financial Officer, Executive Vice President
Geoff Martha, Executive Vice President and President - Restorative Therapies Group
Michael Leavitt, Independent Director
Geoffrey Martha, Executive Vice President and President - Restorative Therapies Group
Randall Hogan, Independent Director
Andrea Goldsmith, Independent Director
Robert Hoedt, Executive Vice President and President - EMEAC
Michael Coyle, Executive Vice President, Group President - Cardiac and Vascular Group

Stock Performance Indicators

Did you try this?

Run Stock Tickers Now


Stock Tickers

Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
All  Next Launch Module

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Additionally see Stocks Correlation. Please also try Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.